2022 annual financial data
Tenax Therapeutics 2022 Operating margin
Tenax Therapeutics 2022 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -11,052,643 USD and net income was -11,047,895 USD.
Operating cash flow was -12,012,873 USD.
Get free Tenax Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -11,052,643 USD
- Net income
- -11,047,895 USD
- Operating cash flow
- -12,012,873 USD